The first FDA-approved treatment for equine protozoal myeloencephalitis (EPM), Marquis, was launched Aug. 23 at Bayer's headquarters in Kansas City, Mo. Robert MacKay, BVSc, PhD, Dipl. ACVIM, of the University of Florida College of Veterinary Medicine, discussed the knowledge, treatment, and prevention of EPM, which is the leading cause of neurologic problems in horses.

(For more o

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners